Allan Reine
2017 - Pieris Pharmaceuticals
In 2017, Allan Reine earned a total compensation of $2M as Chief Financial Officer at Pieris Pharmaceuticals.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Option Awards | $1,662,130 |
| Salary | $148,352 |
| Total | $1,960,482 |
Reine received $1.7M in option awards, accounting for 85% of the total pay in 2017.
Reine also received $150K in bonus and $148.4K in salary.
Rankings
In 2017, Allan Reine's compensation ranked 5,598th out of 14,666 executives tracked by ExecPay. In other words, Reine earned more than 61.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,598 out of 14,666 | 62nd |
Division Services | 1,057 out of 2,428 | 57th |
Major group Engineering, Accounting, Research, Management, And Related Services | 80 out of 185 | 57th |
Industry group Research, Development, And Testing Services | 28 out of 55 | 49th |
Industry Commercial Physical and Biological Research | 27 out of 50 | 46th |
Source: SEC filing on June 14, 2018.
Reine's colleagues
We found three more compensation records of executives who worked with Allan Reine at Pieris Pharmaceuticals in 2017.